The Net Margin of Tasly Pharmaceutical Group Co Ltd (600535.SS) is 11.24%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 11.24% |
| 2023-12-31 | 12.35% |
| 2022-12-31 | -3.07% |
| 2021-12-31 | 29.66% |
| 2020-12-31 | 8.29% |
| 2019-12-31 | 5.27% |
| 2018-12-31 | 8.59% |
| 2017-12-31 | 8.56% |
| 2016-12-31 | 8.43% |
| 2015-12-31 | 11.18% |